US HB2918 | 2017-2018 | 115th Congress
Status
Spectrum: Partisan Bill (Republican 33-1)
Status: Introduced on June 15 2017 - 25% progression, died in committee
Action: 2017-06-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 15 2017 - 25% progression, died in committee
Action: 2017-06-16 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Patients First Act of 2017 This bill amends the Public Health Service Act to require the Department of Health and Human Services (HHS) to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, provided that the techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this bill. HHS must issue guidelines to ensure that any research (including any clinical trial) supported under this bill: (1) is clearly consistent with the standards established in this bill, if conducted using human cells; and (2) is prioritized in terms of potential for near-term clinical benefit in human patients. HHS must report on peer reviewed stem cell research proposals that were not funded.
Title
Patients First Act of 2017
Sponsors
Rep. Jim Banks [R-IN] | Rep. Daniel Lipinski [D-IL] | Rep. Luke Messer [R-IN] | Rep. Trent Franks [R-AZ] |
Rep. Todd Rokita [R-IN] | Rep. Andy Harris [R-MD] | Rep. Jeff Duncan [R-SC] | Rep. Pete Olson [R-TX] |
Rep. Bill Huizenga [R-MI] | Sen. Roger Marshall [R-KS] | Rep. Dennis Ross [R-FL] | Rep. Mark Meadows [R-NC] |
Rep. Tom Cole [R-OK] | Rep. Trent Kelly [R-MS] | Rep. Peter Roskam [R-IL] | Rep. Gus Bilirakis [R-FL] |
Rep. Doug Lamborn [R-CO] | Rep. Francis Rooney [R-FL] | Rep. Glenn Grothman [R-WI] | Rep. Keith Rothfus [R-PA] |
Rep. Ralph Norman [R-SC] | Rep. Tom Graves [R-GA] | Rep. Tim Murphy [R-PA] | Rep. Jeff Fortenberry [R-NE] |
Rep. Brian Babin [R-TX] | Rep. Randy Weber [R-TX] | Rep. Doug LaMalfa [R-CA] | Rep. Louie Gohmert [R-TX] |
Sen. Ted Budd [R-NC] | Rep. Gregg Harper [R-MS] | Rep. Christopher Smith [R-NJ] | Rep. Earl Carter [R-GA] |
Rep. Mike Johnson [R-LA] | Rep. Steve Russell [R-OK] |
History
Date | Chamber | Action |
---|---|---|
2017-06-16 | House | Referred to the Subcommittee on Health. |
2017-06-15 | House | Referred to the House Committee on Energy and Commerce. |
2017-06-15 | House | Introduced in House |
Same As/Similar To
SB2956 (Related) 2018-05-24 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Administrative law and regulatory procedures
Cell biology and embryology
Department of Health and Human Services
Government studies and investigations
Health
Medical ethics
Medical research
Research administration and funding
Cell biology and embryology
Department of Health and Human Services
Government studies and investigations
Health
Medical ethics
Medical research
Research administration and funding
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/115th-congress/house-bill/2918/all-info |
Text | https://www.congress.gov/115/bills/hr2918/BILLS-115hr2918ih.pdf |